Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$36.95 - $82.41 $443,991 - $990,238
-12,016 Closed
0 $0
Q1 2022

May 12, 2022

SELL
$55.7 - $145.79 $83,772 - $219,268
-1,504 Reduced 11.12%
12,016 $914,000
Q4 2021

Feb 11, 2022

SELL
$135.05 - $182.59 $21,472 - $29,031
-159 Reduced 1.16%
13,520 $2.01 Million
Q3 2021

Nov 12, 2021

BUY
$145.58 - $192.14 $23,875 - $31,510
164 Added 1.21%
13,679 $1.99 Million
Q2 2021

Aug 09, 2021

BUY
$134.22 - $202.37 $403,599 - $608,526
3,007 Added 28.62%
13,515 $2.65 Million
Q1 2021

Apr 30, 2021

BUY
$140.25 - $196.86 $19,354 - $27,166
138 Added 1.33%
10,508 $1.9 Million
Q4 2020

Feb 02, 2021

BUY
$126.47 - $163.7 $1.31 Million - $1.7 Million
10,370 New
10,370 $1.47 Million

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.33B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track British Columbia Investment Management Corp Portfolio

Follow British Columbia Investment Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of British Columbia Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on British Columbia Investment Management Corp with notifications on news.